Does IVOSIDENIB Cause Malignant neoplasm progression? 38 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 38 reports of Malignant neoplasm progression have been filed in association with IVOSIDENIB (TIBSOVO). This represents 2.2% of all adverse event reports for IVOSIDENIB.
38
Reports of Malignant neoplasm progression with IVOSIDENIB
2.2%
of all IVOSIDENIB reports
9
Deaths
12
Hospitalizations
How Dangerous Is Malignant neoplasm progression From IVOSIDENIB?
Of the 38 reports, 9 (23.7%) resulted in death, 12 (31.6%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IVOSIDENIB. However, 38 reports have been filed with the FAERS database.
What Other Side Effects Does IVOSIDENIB Cause?
Off label use (613)
Fatigue (144)
Diarrhoea (100)
Nausea (100)
Disease progression (86)
Differentiation syndrome (80)
Product dose omission issue (68)
Drug ineffective (64)
Platelet count decreased (61)
Electrocardiogram qt prolonged (58)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which IVOSIDENIB Alternatives Have Lower Malignant neoplasm progression Risk?
IVOSIDENIB vs IXABEPILONE
IVOSIDENIB vs IXAZOMIB
IVOSIDENIB vs IXEKIZUMAB
IVOSIDENIB vs JAKAFI
IVOSIDENIB vs JAKAVI